Mr. Martin has served as a member of the Board of Directors of Deciphera Pharmaceuticals since February 2015. He has more than 35 years of experience in clinical diagnostics, finance, and general business administration. Mr. Martin served as the President and Chief Executive Officer of Clinical Reference Laboratory from January 2015 to August 2019, having previously served as Executive Vice President and Chief Administrative Officer of Clinical Reference Laboratory from February 2014 to January 2015. Prior to joining Clinical Reference Laboratory, Mr. Martin held senior executive roles with Viracor-IBT Laboratories, a clinical diagnostic laboratory specializing in infectious disease and immunology, first as its Chief Financial Officer and then as its President and Chief Executive Officer. Prior to Viracor, Mr. Martin was with George K. Baum & Company, where he served as Managing Director leading the firm’s middle market investment banking and strategic advisory practice. Mr. Martin’s career also includes 11 years in management roles with Sprint Corporation and General Electric. He previously served as the Chairman of the Board of FormFox, Inc., a subsidiary of CHC. Mr. Martin holds a B.S. in Finance from Kansas State University.